Netherlands Gene Therapy Market to 2032
Overview
The Netherlands Gene Therapy Market is expected to reach a 478.02 USD Billion by 2032 and is projected to grow at a CAGR of 22.03% from 2025 to 2032.
Revenue, 2024 (USD Billion)
156.14
Forecast, 2032 (USD Billion)
478.02
CAGR, 2024 - 2032
22.03%
Report Coverage
Netherlands
Netherlands Gene Therapy Market 2018-2032 USD Billion
Netherlands Gene Therapy Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 156.14 USD Billion
- Projected Market Size (2032): 478.02 USD Billion
- CAGR (2025-2032): 22.03%
Key Findings of Netherlands Gene Therapy Market
- The Netherlands Gene Therapy Market was valued at 156.14 USD Billion in 2024.
- The Netherlands Gene Therapy Market is likely to grow at a CAGR of 22.03% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Viral Vector in Vector Segment accounted for the largest share of the market with a revenue of 121.93 USD Billion
- The fastest growing segment Oncological Disorders in Application Segment grew Fastest with a CAGR of 24.91% during the forecast period from 2024 to 2032.
Netherlands Gene Therapy Market Scope
Netherlands Gene Therapy Market Segmentation & Scope
Method
- In-Vivo
- Ex-Vivo
Vector
- Non-Viral Vector
- Viral Vector
Application
- Other Diseases
- Neurological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Infectious Disease
- Oncological Disorders
End User
- Others
- Research Institutes
- Hospitals
- Cancer Institutes
Netherlands Gene Therapy Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 156.14 USD Billion |
| Market Value in 2032 | 478.02 USD Billion |
| CAGR (2025-2032) | 22.03% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Method,Vector,Application,End User |
Regional Insights:
-
Leading Market (2024-2032): Netherlands, leading in terms of revenue 156.14 USD Billion in 2024
- Key Country: Netherlands, leading in terms of revenue with value of 156.14 USD Billion in 2024.
Segments and Scope
-
Netherlands Gene Therapy Market to 2032, By Method
- Ex-Vivo is the largest segment in Netherlands Gene Therapy Market to 2032 with a revenue of 119.13 USD Billion in the year 2024.
- Ex-Vivo is the Fastest growing segment in Netherlands Gene Therapy Market to 2032 with a Growth rate of 23.16 % in forecast period 2025-2032.
-
Netherlands Gene Therapy Market to 2032, By Vector
- Viral Vector is the largest segment in Netherlands Gene Therapy Market to 2032 with a revenue of 121.93 USD Billion in the year 2024.
- Viral Vector is the Fastest growing segment in Netherlands Gene Therapy Market to 2032 with a Growth rate of 23.18 % in forecast period 2025-2032.
-
Netherlands Gene Therapy Market to 2032, By Application
- Oncological Disorders is the largest segment in Netherlands Gene Therapy Market to 2032 with a revenue of 73.51 USD Billion in the year 2024.
- Oncological Disorders is the Fastest growing segment in Netherlands Gene Therapy Market to 2032 with a Growth rate of 24.91 % in forecast period 2025-2032.
-
Netherlands Gene Therapy Market to 2032, By End User
- Cancer Institutes is the largest segment in Netherlands Gene Therapy Market to 2032 with a revenue of 69.45 USD Billion in the year 2024.
- Cancer Institutes is the Fastest growing segment in Netherlands Gene Therapy Market to 2032 with a Growth rate of 23.72 % in forecast period 2025-2032.
Netherlands Gene Therapy Market Company Share Analysis
| Company Name |
|
||
| Oxford Biomedica | |||
| Novartis AG | |||
| Kite Pharma Inc. | |||
| Biogen | |||
| Bristol-Myers Squibb Company | |||
Netherlands Gene Therapy Market Geographical Sales Distribution, 2018-2032 USD Billion
Netherlands Gene Therapy Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Netherlands Gene Therapy Market is segmented based on Segmentation Method,Vector,Application,End User.
Netherlands Gene Therapy Market was valued at USD 156.14(Revenue in USD Billion) in 2021.
Netherlands Gene Therapy Market is projected to grow at a CAGR of 22.03% during the forecast period of 2024 to 2032.
The Viral Vector segment is expected to dominate the Netherlands Gene Therapy Market, holding a largest market share of 121.93 USD Billion in 2024
Netherlands Gene Therapy Market Scope
Netherlands Gene Therapy Market Segmentation & Scope
Method
- In-Vivo
- Ex-Vivo
Vector
- Non-Viral Vector
- Viral Vector
Application
- Other Diseases
- Neurological Disorders
- Rare Diseases
- Cardiovascular Diseases
- Infectious Disease
- Oncological Disorders
End User
- Others
- Research Institutes
- Hospitals
- Cancer Institutes
Frequently Asked Questions
The Netherlands Gene Therapy Market is segmented based on Segmentation Method,Vector,Application,End User.
Netherlands Gene Therapy Market was valued at USD 156.14(Revenue in USD Billion) in 2021.
Netherlands Gene Therapy Market is projected to grow at a CAGR of 22.03% during the forecast period of 2024 to 2032.
The estimated market value of the Netherlands Gene Therapy Market for final year is USD 478.02 (USD Billion).
Netherlands Gene Therapy Market Company Profiling
Frequently Asked Questions
The Netherlands Gene Therapy Market is segmented based on Segmentation Method,Vector,Application,End User.
Netherlands Gene Therapy Market was valued at USD 156.14(Revenue in USD Billion) in 2021.
Netherlands Gene Therapy Market is projected to grow at a CAGR of 22.03% during the forecast period of 2024 to 2032.
The estimated market value of the Netherlands Gene Therapy Market for final year is USD 478.02 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.